$LSAK

LESAKA TECHNOLOGIES INC

CIK:0001041514|SEC Filings

Consolidated Statement Of Operations - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2024
REVENUE (Note 16)	$ 721,554	$ 659,701	$ 564,222
EXPENSE
Cost of goods sold, IT processing, servicing and support, exclusive of depreciation and amortization shown separately below	490,834	487,186	443,293
Cost of goods sold, IT processing, servicing and support, exclusive of depreciation and amortization shown separately below	153,473	123,727	87,027
Movement in allowance for credit losses (Note 4)	12,796	8,011	5,158
Depreciation and amortization	47,346	33,721	23,665
Transaction costs related to Adumo, Utilities and Bank Zero acquisitions and certain compensation costs (Note 3)	389	16,159	2,325
Impairment loss (Note 10)	4,035	18,863	0
OPERATING INCOME (LOSS)	12,681	(27,966)	2,754
CHANGE IN FAIR VALUE OF EQUITY SECURITIES (Note 6 and 9)	2,593	(59,828)	0
OTHER INCOME (Note 13)	3,883	0	0
REVERSAL OF ALLOWANCE FOR DOUBTFUL LOAN RECEIVABLE (Note 4 and Note 9)	1,500	0	250
NET LOSS ON IMPAIRMENT OF EQUITY-ACCOUNTED INVESTMENT/ LOSS ON DISPOSAL OF EQUITY-ACCOUNTED INVESTMENT (Note 9)	584	161	0
LOSS ON DISPOSAL OF EQUITY SECURITIES (Note 3)	730	0	0
INTEREST INCOME	2,889	2,596	2,294
INTEREST EXPENSE	18,506	21,824	19,171
INCOME (LOSS) BEFORE INCOME TAX EXPENSE (BENEFIT)	3,726	(107,183)	(13,873)
INCOME TAX EXPENSE (BENEFIT) (Note 18)	1,429	(15,982)	3,363
INCOME (LOSS) BEFORE EARNINGS (LOSS) FROM EQUITY-ACCOUNTED INVESTMENTS	2,297	(91,201)	(17,236)
EARNINGS (LOSS) FROM EQUITY-ACCOUNTED INVESTMENTS (Note 9)	215	114	(1,279)
NET INCOME (LOSS)	2,512	(91,087)	(18,515)
ADD NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST	246	130	0
NET INCOME (LOSS) ATTRIBUTABLE TO LESAKA	$ 2,758	$ (90,957)	$ (18,515)
Net earnings (loss) per share, in United States dollars (Note 19):
Basic earnings (loss) attributable to Lesaka shareholders	$ 0.03	$ (1.19)	$ (0.29)
Diluted earnings (loss) attributable to Lesaka shareholders	$ 0.03	$ (1.19)	$ (0.29)
Services Rendered [Member]
REVENUE (Note 16)	$ 630,377	$ 613,201	$ 529,818
Loan-based Fees Received [Member]
REVENUE (Note 16)	65,696	37,344	29,948
Sale of Goods [Member]
REVENUE (Note 16)	10,158	9,157	4,456
Income from Rentals [Member]
REVENUE (Note 16)	$ 15,323	$ 0	$ 0

Consolidated Statement Of Cashflows - USD ($)	12 Months Ended
Consolidated Statement Of Cashflows - USD ($)	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities
Net income (loss)	$ 2,512,000	$ (91,087,000)	$ (18,515,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	47,346,000	33,721,000	23,665,000
Impairment loss (Note 10)	4,035,000	18,863,000	0
Movement in allowance for credit losses	12,796,000	8,011,000	5,158,000
Fair value adjustment related to financial liabilities	(238,000)	(120,000)	(853,000)
Change in fair value of equity securities (Note 6 and 9)	(2,593,000)	59,828,000	0
Other income	(3,883,000)	0	0
Loss on disposal of equity securities (Note 3)	730,000	0	0
Loss on disposal of equity-accounted investment (Note 9)	584,000	161,000	0
Gain on deconsolidation of subsidiary	(848,000)	0	0
(Profit) Loss on disposal of property, plant and equipment	(316,000)	13,000	(305,000)
Stock-based compensation charge (Note 17)	6,969,000	9,550,000	7,911,000
(Earnings) Loss from equity-accounted investments (Note 9)	(215,000)	(114,000)	1,279,000
Reversal of allowance for doubtful loans	(1,500,000)	0	(250,000)
Dividends received from equity-accounted investments	105,000	96,000	95,000
Interest payable	20,000	4,723,000	1,119,000
Facility fee amortized (Note 12)	413,000	429,000	443,000
Increase (Decrease) in income taxes payable	402,000	485,000	(400,000)
Deferred tax benefit	(9,451,000)	(21,739,000)	(2,712,000)
Decrease (Increase) in accounts receivable (Note 20)	3,500,000	1,081,000	(10,873,000)
Increase in finance loans receivable (Note 20)	(34,421,000)	(34,614,000)	(10,029,000)
Decrease in inventory	6,704,000	169,000	9,840,000
Increase (Decrease) in accounts payable and other payables	19,793,000	(12,164,000)	23,216,000
Deferred consideration included in other payables (Note 3 and Note 13)	0	13,586,000	0
Net cash provided by (used in) operating activities	52,444,000	(9,122,000)	28,789,000
Cash flows from investing activities
Capital expenditures	(20,646,000)	(17,199,000)	(12,665,000)
Proceeds from disposal of property, plant and equipment	1,849,000	1,938,000	1,565,000
Acquisition of intangible assets	(4,403,000)	(3,900,000)	(294,000)
Acquisitions, net of cash acquired (Note 3)	(11,117,000)	(12,946,000)	(1,583,000)
Proceeds from disposal of equity securities (Note 6 and 9)	2,971,000	16,441,000	0
Investment in equity securities	(450,000)	0	0
Cash disposed on disposal of subsidiary	(165,000)	0	0
Proceeds from disposal of equity-accounted investment (Note 9)	0	0	3,508,000
Repayment of loans by equity-accounted investments	0	0	250,000
Acquisition of insurance entity investments	(4,598,000)	0	0
Net change in settlement assets	10,822,000	4,324,000	(7,196,000)
Net cash used in investing activities	(25,737,000)	(11,342,000)	(16,415,000)
Cash flows from financing activities
Proceeds from bank overdraft (Note 12)	123,712,000	98,616,000	182,990,000
Repayment of bank overdraft (Note 12)	(129,417,000)	(90,309,000)	(199,642,000)
Long-term borrowings utilized (Note 12)	6,949,000	190,061,000	23,728,000
Repayment of long-term borrowings (Note 12)	(13,741,000)	(149,511,000)	(20,073,000)
Non-refundable deal origination fees/ guarantee fees (Note 12)	(285,000)	(970,000)	0
Repurchase of shares of common stock and treasury stock (Note 14)	(339,000)	(13,660,000)	(1,495,000)
Proceeds from exercise of stock options	63,000	116,000	165,000
Acquisition of non-controlling interests (Note 14)	(3,538,000)	0	0
Dividends paid to non-controlling interest	0	(432,000)	0
Net change in settlement obligations	(10,390,000)	(4,179,000)	7,214,000
Net cash (used in) provided by financing activities	(26,986,000)	29,732,000	(7,113,000)
Effect of exchange rate changes on cash	5,178,000	1,453,000	2,025,000
Net increase in cash, cash equivalents and restricted cash	4,899,000	10,721,000	7,286,000
Cash, cash equivalents and restricted cash - beginning of period	76,639,000	65,918,000	58,632,000
Cash, cash equivalents and restricted cash - end of period (Note 20)	$ 81,538,000	$ 76,639,000	$ 65,918,000

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025
CURRENT ASSETS
Cash and cash equivalents	$ 81,409	$ 76,520
Restricted cash related to short-term credit facilities (Note 12)	129	119
Accounts receivable, net and other receivables (Note 4)	43,765	42,525
Finance loans receivable, net (Note 4)	103,810	74,110
Inventory (Note 5)	20,113	23,551
Total current assets before settlement assets	249,226	216,825
Settlement assets	18,504	27,098
Total current assets	267,730	243,923
PROPERTY, PLANT AND EQUIPMENT, NET (Note 1 and Note 7)	50,212	44,924
OPERATING LEASE RIGHT-OF-USE (Note 8)	20,161	9,691
EQUITY-ACCOUNTED INVESTMENTS (Note 9)	295	199
GOODWILL (Note 10)	215,298	199,395
INTANGIBLE ASSETS, NET (Note 10), including integrated platform - 2026: $73,211; 2025: $79,343	123,425	139,215
DEFERRED TAX ASSETS, NET	12,470	10,338
OTHER LONG-TERM ASSETS, including equity securities (Note 9 and 11)	9,697	3,809
TOTAL ASSETS	699,288	651,494
CURRENT LIABILITIES
Short-term credit facilities (Note 12)	20,671	24,469
Accounts payable	23,986	19,867
Other payables (Note 13)	83,262	76,035
Operating lease liability - current (Note 8)	4,408	4,007
Current portion of long-term borrowings (Note 12)	16,114	11,956
Income taxes payable	1,691	1,400
Total current liabilities before settlement obligations	150,132	137,734
Settlement obligations	18,530	26,695
Total current liabilities	168,662	164,429
DEFERRED TAX LIABILITIES, NET	28,379	33,921
OPERATING LEASE LIABILITY - LONG TERM (Note 8)	19,338	6,129
LONG-TERM BORROWINGS (Note 12)	194,597	188,813
OTHER LONG-TERM LIABILITIES, including insurance policy liabilities (Note 11)	3,988	2,991
TOTAL LIABILITIES	414,964	396,283
REDEEMABLE COMMON STOCK (Note 14)	78,972	88,957
EQUITY
COMMON STOCK (Note 14) Authorized: 200,000,000 with $0.001 par value; Issued and outstanding shares, net of treasury - 2026: 83,306,794; 2025: 81,249,097	84	84
PREFERRED STOCK Authorized shares: 50,000,000 with $0.001 par value; Issued and outstanding shares, net of treasury: 2026: - ; 2025: -
ADDITIONAL PAID-IN CAPITAL	152,554	135,505
TREASURY SHARES, AT COST: 2026: 2,548,472; 2025: 3,999,049	(234)	(7,059)
ACCUMULATED OTHER COMPREHENSIVE LOSS (Note 15)	(166,319)	(185,626)
RETAINED EARNINGS	219,267	216,509
TOTAL LESAKA EQUITY	205,352	159,413
NON-CONTROLLING INTEREST	0	6,841
TOTAL EQUITY	205,352	166,254
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND SHAREHOLDERS' EQUITY	$ 699,288	$ 651,494